Podcast explores father's quest for ultra‑rare disease therapy, telehealth GLP‑1 prescribing probe and fugitive posing as biotech exec

The latest episode of STAT’s "The Readout Loud" podcast examines three distinct stories that intersect with the biotech world. Hosts Allison DeAngelis and Elaine Chen sit down with colleagues Jason Mast and Matthew Herper, and invite guest Matt Wilsey, to discuss the topics in depth.

One segment follows Matt Wilsey, a father who is driving the development of a treatment for his daughter’s ultra‑rare disease. The conversation explores the scientific and logistical hurdles involved in creating a therapy for a condition that affects very few patients.

The episode also reviews STAT’s investigation into LifeMD, a telehealth provider that partners with Novo Nordisk. The report raises concerns about the company’s prescribing practices for GLP‑1 weight‑loss drugs, suggesting potential overuse or inappropriate prescriptions.

Finally, the hosts touch on a separate allegation that a wanted fugitive has been masquerading as a biotech executive, adding a layer of intrigue to the broader discussion of industry integrity.